The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
REsect: Blinded assessment of amenability to potentially curative treatment of previously unresectable colorectal cancer liver metastases (CRC LM) after chemotherapy ± RadioEmbolization (SIRT) in the randomized SIRFLOX trial.
 
Benjamin Garlipp
Honoraria - Amgen; Merck; Roche; Sirtex Medical
Consulting or Advisory Role - Amgen; Merck; Roche; Sirtex Medical
Research Funding - Sirtex Medical (Inst)
 
Peter Gibbs
Honoraria - Amgen; Merck; Roche; SERVIER; Sirtex Medical
Research Funding - Amgen (Inst); Merck Serono (Inst); Roche (Inst); Ventana Medical Systems (Inst)
 
Guy A. Van Hazel
No Relationships to Disclose
 
Rohan Jeyarajah
No Relationships to Disclose
 
Robert C. G. Martin
Consulting or Advisory Role - Angiodynamics
 
Christiane J. Bruns
No Relationships to Disclose
 
Hauke Lang
No Relationships to Disclose
 
Derek M. Manas
No Relationships to Disclose
 
Giuseppe Maria Ettorre
No Relationships to Disclose
 
Fernando Pardo
No Relationships to Disclose
 
Vincent Donckier
No Relationships to Disclose
 
Christoph Benckert
No Relationships to Disclose
 
Thomas M van Gulik
No Relationships to Disclose
 
Diane Goere
No Relationships to Disclose
 
Michael Schoen
No Relationships to Disclose
 
Johann Pratschke
No Relationships to Disclose
 
Wolf O. Bechstein
No Relationships to Disclose
 
Antonio Martínez de la Cuesta
No Relationships to Disclose
 
Shola Adeyemi
No Relationships to Disclose
 
Max Seidensticker
No Relationships to Disclose